ARTL stock news
This page provides real-time market news, earnings updates, and company announcements related to Artelo Biosciences, Inc. (ARTL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-21 01:28 EST
COAI's Sudden Price Decline: Managing Immediate Fluctuations and Sustained Strength
Bitget-RWA2025-11-12 20:04:05
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
Finviz2026-02-24 13:03:09
Artelo Biosciences Announces Reverse Stock Split
Finviz2026-03-06 13:04:14
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
Finviz2026-03-18 11:48:47
Clinical Collaboration and Funding Arrangement: Artelo Biosciences, Inc. (NASDAQ: ARTL) announces the signing of a third-party fully funded clinical research agreement to advance the evaluation of its candidate drug ART27.13 in glaucoma patients.
老虎证券2026-03-18 11:56:20
Theravance Biopharma’s $70M Restructuring Cash Flow Catalyst Now Outpaces Missed $75M Milestone Hopes
101 finance2026-03-18 14:34:26
X’s Reliability Crisis Sparks Behavioral Overreaction—Is the Market Overestimating the Risk?
101 finance2026-03-18 15:52:02
Artelo Biosciences Shares Soar 50% on Pre-Market Trading Frenzy, 295th-Ranked $420M Volume Signals Glaucoma Trial Spark
101 finance2026-03-19 00:16:04
Artelo Biosciences Surges 28% Intraday as Mystery Drives Volatility and Speculation
101 finance2026-03-20 14:18:57
Artelo Biosciences Jumps 28% During the Day Amid Uncertainty Fueling Market Fluctuations and Rumors
101 finance2026-03-20 14:18:57
Clinical Collaboration and Funding Arrangement: Artelo Biosciences, Inc. (NASDAQ: ARTL) announces the signing of a third-party fully funded clinical research agreement to advance the evaluation of its candidate drug ART27.13 in glaucoma patients.
老虎证券2026-03-18 11:56:20
Theravance Biopharma’s $70M Restructuring Cash Flow Catalyst Now Outpaces Missed $75M Milestone Hopes
101 finance2026-03-18 14:34:26
X’s Reliability Crisis Sparks Behavioral Overreaction—Is the Market Overestimating the Risk?
101 finance2026-03-18 15:52:02
Artelo Biosciences Shares Soar 50% on Pre-Market Trading Frenzy, 295th-Ranked $420M Volume Signals Glaucoma Trial Spark
101 finance2026-03-19 00:16:04
Artelo Biosciences Surges 28% Intraday as Mystery Drives Volatility and Speculation
101 finance2026-03-20 14:18:57
Artelo Biosciences Jumps 28% During the Day Amid Uncertainty Fueling Market Fluctuations and Rumors
101 finance2026-03-20 14:18:57
ARTL stock chart
ARTL stock detailsARTL stock price change
On the last trading day, ARTL stock closed at 3.94 USD, with a price change of 12.13% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more